More insights from the world of Life Sciences & Meet

Cycle Pharmaceuticals: The Company Behind the First FDA-Approved Drug for Alkaptonuria

By Rosie Barden

Cycle Pharmaceuticals: The Company Behind the First FDA-Approved Drug for Alkaptonuria

Read More
Life Sciences Talent Trends: 5 Key Takeaways from the First Half of 2025

By Rosie Barden

Life Sciences Talent Trends: 5 Key Takeaways from the First Half of 2025

Read More
Beth Pugh’s Work Experience at Meet Life Sciences

By Rosie Barden

Beth Pugh’s Work Experience at Meet Life Sciences

Read More
Talent Spotlight: Chloe’s Journey at Meet Life Sciences

By Rosie Barden

Talent Spotlight: Chloe’s Journey at Meet Life Sciences

Read More
Meet Ranks 50th in SIA’s Fastest-Growing US Staffing Firms List

By Hannah Haigh

Meet Ranks 50th in SIA’s Fastest-Growing US Staffing Firms List

Read More
Sarcoma Treatments: Recent Advancements in one of the Rarest and ‘Loneliest’ Cancer Forms

By Rosie Barden

Sarcoma Treatments: Recent Advancements in one of the Rarest and ‘Loneliest’ Cancer Forms

Read More
The Meet Passport: Shannon & Brocke’s Trip to London

By Rosie Barden

The Meet Passport: Shannon & Brocke’s Trip to London

Read More
Meet Life Sciences Launches Mx: A Standalone Executive Search Brand for the Life Sciences Industry

By Hannah Haigh

Meet Life Sciences Launches Mx: A Standalone Executive Search Brand for the Life Sciences Industry

Read More
Arcellx: The Company Making Exciting Progress for Patients with Relapsed or Refractory Multiple Myeloma

By Rosie Barden

Arcellx: The Company Making Exciting Progress for Patients with Relapsed or Refractory Multiple Myeloma

Read More
Meet Life Sciences 2025. Meet Life Sciences Ltd., Meet Recruitment Inc. and Meet Personalberatung GmbH are all subsidiaries of Meet Life Sciences Group (No. 13556131) a company registered in England and Wales at Irongate House, 22-30 Dukes Place, London, EC3A 7LP.
Site by Venn
#ifdef JOBLISTINGS